Status:

UNKNOWN

Finding the Latent Treponema Pallidum

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

Syphilis

Eligibility:

All Genders

18-75 years

Brief Summary

Some syphilitic patients remain in a serologically positive state after the recommended therapy. Whether a serofast state could represent a persistent low-level infection by Treponema pallidum is stil...

Detailed Description

Some syphilitic patients remain in a serologically positive state after the recommended therapy. Whether a serofast state could represent a persistent low-level infection by Treponema pallidum is stil...

Eligibility Criteria

Inclusion

  • All clinical diagnosis of syphilis cases

Exclusion

  • Auto-immune disease (such as SLE)
  • Lyme disease

Key Trial Info

Start Date :

August 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2019

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03754517

Start Date

August 1 2016

End Date

December 1 2019

Last Update

March 28 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

PekingUMCH

Beijing, China